Skip to content
Fencer Intel
medium 5.3

CVE-2026-21974 json

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform).

published 9mo ago modified 4mo ago also EUVD-2026-3538

cvss
5.3
version 3.1, CNA
cisa kev
Not listed
not in CISA's catalog
epss
0.3%
EPSS 0.3% chance of exploitation in 30 days, percentile 17%
public exploits
0
none known

Summary

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

Is CVE-2026-21974 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.

Check with Fencer

CISA SSVC

Exploitation
none
Automatable
yes
Technical impact
partial
Assessed
9mo ago

Exploit prediction

0.26% chance of exploitation in the next 30 days, higher than 17% of all scored CVEs (FIRST EPSS, 2026-11-09).

CVSS scores

assigned by version score vector
CNA 3.1 5.3 CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

Affected products

  • Oracle Corporation Oracle Life Sciences Central Designer

Classification

Weakness
  • CWE-200 Exposure of Sensitive Information to an Unauthorized Actor

References

Sources

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.